Drugs / P-TIOX
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07222176 | Jun 2025 → Jun 2026 overdue | noninfectious dermatoses of eyelid | Main Line Center for Laser Surgery | Active not recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | P-TIOX | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07222176 ↗ |
| Modality | Peptide | “topical peptide-based cosmeceutical (P-TIOX)” NCT07222176 ↗ |
| Route | Topical | “applying a topical peptide-based cosmeceutical (P-TIOX) daily to one periocular area” NCT07222176 ↗ |